Lineage Cell Therapeutics, Inc.
AMEX:LCTX
0.95 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8.945 | 14.703 | 3.896 | 0.773 | 1.478 | 1.416 | 1.792 | 2.252 | 2.534 | 1.946 | 2.861 | 1.693 | 4.355 | 3.68 | 1.925 | 1.504 | 1.046 | 1.162 | 0.903 | 0.688 | 0.556 | 0.387 | 0.152 | 0.052 | 1.038 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Cost of Revenue
| 1.363 | 0.728 | 1.426 | 0.385 | 0.412 | 0.302 | 0.168 | 0.358 | 1.107 | 0.837 | 0.793 | 0.434 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.075 | -0.06 | 0 | 0 | 0 | 0 | 0 | 0.6 | 0.4 |
| Gross Profit
| 7.582 | 13.975 | 2.47 | 0.388 | 1.066 | 1.114 | 1.624 | 1.894 | 1.427 | 1.109 | 2.068 | 1.259 | 4.355 | 3.68 | 1.925 | 1.504 | 1.046 | 1.162 | 0.903 | 0.688 | 0.556 | 0.387 | 0.152 | 0.128 | 1.097 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | -0.5 | -0.3 |
| Gross Profit Ratio
| 0.848 | 0.95 | 0.634 | 0.502 | 0.721 | 0.787 | 0.906 | 0.841 | 0.563 | 0.57 | 0.723 | 0.743 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2.438 | 1.057 | 1 | 1 | 1 | 1 | 1 | -5 | -3 |
| Reseach & Development Expenses
| 15.575 | 13.987 | 33.914 | 12.317 | 17.948 | 20.955 | 24.024 | 36.106 | 42.604 | 37.533 | 26.609 | 18.117 | 13.7 | 7.892 | 2.969 | 1.706 | 0.968 | 1.422 | 1.526 | 1.123 | 0.903 | 1.103 | 1.685 | 3.363 | 4.901 | 1.7 | 2.1 | 0 | 1.8 | 0.8 | 0 | 0 |
| General & Administrative Expenses
| 17.302 | 22.508 | 18.212 | 15.571 | 24.031 | 24.726 | 19.922 | 28.426 | 29.134 | 17.556 | 15.559 | 10.365 | 9.342 | 5.64 | 2.476 | 2.62 | 1.301 | 1.492 | 1.396 | 1.484 | 1.261 | 1.318 | 1.961 | 1.78 | 1.897 | 0 | 1.2 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -0.562 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 16.74 | 22.508 | 18.212 | 15.571 | 24.031 | 24.726 | 19.922 | 28.426 | 29.134 | 17.556 | 15.559 | 10.365 | 9.342 | 5.64 | 2.476 | 2.62 | 1.301 | 1.492 | 1.396 | 1.484 | 1.261 | 1.318 | 1.961 | 1.78 | 1.897 | 0.7 | 1.2 | 2.1 | 0.8 | 0.9 | 0.8 | 0.4 |
| Other Expenses
| -0.004 | -2.152 | -0.445 | -1.053 | -2.037 | -1.315 | 1.449 | -0.403 | -0.16 | -0.375 | -0.209 | -0.318 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.083 | 0 | 0 | 0.075 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 32.315 | 36.495 | 51.681 | 26.835 | 39.942 | 42.109 | 42.28 | 60.861 | 67.236 | 51.792 | 40.595 | 26.259 | 23.041 | 13.532 | 5.445 | 4.326 | 2.268 | 2.914 | 2.922 | 2.657 | 2.246 | 2.422 | 3.647 | 5.218 | 6.857 | 2.4 | 3.3 | 2.1 | 2.6 | 1.7 | 0.8 | 0.4 |
| Operating Income
| -24.733 | -22.52 | -49.211 | -26.447 | -38.876 | -41.795 | -38.902 | -58.967 | -65.809 | -50.683 | -55.985 | -25.001 | -18.686 | -9.852 | -3.52 | -2.823 | -1.222 | -1.752 | -2.018 | -1.969 | -1.69 | -2.035 | -3.495 | -5.09 | -5.76 | -2.1 | -3.2 | -2 | -2.5 | -1.6 | -1.3 | -0.7 |
| Operating Income Ratio
| -2.765 | -1.532 | -12.631 | -34.213 | -26.303 | -29.516 | -21.709 | -26.184 | -25.97 | -26.04 | -19.568 | -14.768 | -4.291 | -2.677 | -1.829 | -1.877 | -1.168 | -1.508 | -2.235 | -2.86 | -3.037 | -5.257 | -23.003 | -96.972 | -5.552 | -7 | -32 | -20 | -25 | -16 | -13 | -7 |
| Total Other Income Expenses Net
| 1.451 | -3.292 | 5.941 | 4.523 | 19.642 | -6.846 | 18.059 | 78.335 | 3.499 | -0.384 | -17.663 | -0.325 | 0.213 | -2.211 | 0.03 | 0.008 | 0.017 | 0.044 | 0.023 | 0.032 | 1.038 | 0.021 | 0.114 | 0.165 | 0.28 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 |
| Income Before Tax
| -23.282 | -25.812 | -43.27 | -21.924 | -19.234 | -47.13 | -23.289 | 18.621 | -62.65 | -51.155 | -56.19 | -25.306 | -18.474 | -12.063 | -3.49 | -2.815 | -1.205 | -1.708 | -1.995 | -1.936 | -0.651 | -2.014 | -3.38 | -4.925 | -5.48 | -2 | -3 | -1.9 | -2.3 | -1.4 | -1.2 | -0.6 |
| Income Before Tax Ratio
| -2.603 | -1.756 | -11.106 | -28.362 | -13.014 | -33.284 | -12.996 | 8.269 | -24.724 | -26.282 | -19.64 | -14.949 | -4.242 | -3.278 | -1.813 | -1.872 | -1.152 | -1.469 | -2.209 | -2.813 | -1.171 | -5.204 | -22.251 | -93.824 | -5.282 | -6.667 | -30 | -19 | -23 | -14 | -12 | -6 |
| Income Tax Expense
| -1.803 | 0.541 | -4.706 | -1.239 | -7.407 | -0.346 | -37.29 | -175.948 | -4.516 | -7.376 | -3.281 | -3.568 | -2.384 | 3.419 | -0.06 | -0.015 | 0.388 | -0.089 | -0.046 | 1.084 | -2.077 | 0.79 | 0.05 | -0.331 | -0.56 | 0.1 | -0.2 | 0.1 | -0.1 | -0.1 | -0.1 | 0.1 |
| Net Income
| -21.486 | -26.353 | -38.564 | -20.685 | -11.827 | -45.99 | -19.976 | 33.572 | -46.991 | -36.412 | -43.883 | -21.426 | -16.516 | -11.185 | -5.144 | -3.781 | -1.438 | -1.865 | -2.074 | -3.085 | -1.742 | -2.845 | -3.659 | -4.925 | -5.48 | -2.1 | -3 | -2 | -2.4 | -1.5 | -1.2 | -0.7 |
| Net Income Ratio
| -2.402 | -1.792 | -9.898 | -26.759 | -8.002 | -32.479 | -11.147 | 14.908 | -18.544 | -18.707 | -15.338 | -12.656 | -3.793 | -3.039 | -2.672 | -2.514 | -1.375 | -1.605 | -2.297 | -4.482 | -3.131 | -7.351 | -24.084 | -93.824 | -5.282 | -7 | -30 | -20 | -24 | -15 | -12 | -7 |
| EPS
| -0.12 | -0.16 | -0.23 | -0.14 | -0.081 | -0.36 | -0.17 | 0.35 | -0.59 | -0.55 | -0.81 | -0.44 | -0.35 | -0.28 | -0.18 | -0.16 | -0.063 | -0.083 | -0.12 | -0.18 | -0.12 | -0.23 | -0.32 | -0.45 | -0.51 | -0.21 | -0.34 | -0.26 | -0.3 | -0.25 | -0.23 | -0.18 |
| EPS Diluted
| -0.12 | -0.16 | -0.23 | -0.14 | -0.081 | -0.36 | -0.17 | 0.34 | -0.59 | -0.55 | -0.81 | -0.44 | -0.35 | -0.28 | -0.18 | -0.16 | -0.063 | -0.083 | -0.12 | -0.18 | -0.12 | -0.23 | -0.32 | -0.45 | -0.51 | -0.21 | -0.34 | -0.24 | -0.3 | -0.25 | -0.23 | -0.18 |
| EBITDA
| -24.041 | -19.824 | -52.791 | -25.012 | -54.301 | -32.191 | -53.97 | -142.376 | -63.169 | -50.674 | -17.12 | -24.994 | -16.533 | -6.713 | -3.516 | -2.813 | -1.239 | -1.77 | -2.035 | -0.952 | -1.918 | -1.549 | -3.313 | -5.18 | -5.98 | -2.2 | -3.4 | -2.1 | -2.7 | -1.8 | -1.4 | -0.8 |
| EBITDA Ratio
| -2.688 | -1.348 | -13.55 | -32.357 | -36.74 | -22.734 | -30.117 | -63.222 | -24.929 | -26.035 | -5.984 | -14.764 | -3.796 | -1.824 | -1.826 | -1.871 | -1.185 | -1.523 | -2.253 | -1.383 | -3.446 | -4.001 | -21.81 | -98.683 | -5.764 | -7.333 | -34 | -21 | -27 | -18 | -14 | -8 |